Early phase trials and precision medicine: Dr. Kurzrock

The emerging field of precision medicine (also called “personalized medicine”) is changing the treatment landscape for colorectal cancer.

In this conversation with PALTOWN Scientific Director Dr. Manju George, Dr. Kurzrock of UC San Diego discusses how phase I clinical trials are evolving — in part due to precision medicine — to fit patients, rather than the other way around. Dr. Kuzrock also addresses common misconceptions about phase I trials.

To learn more about precision medicine, visit our Precision Medicine Learning Center.